New TAVI research published by Imperial team!

The TAVI team at Imperial continue to publish research that improves patient care.

Their latest work suggests that Aspirin alone is adequate, and dual anti platelets (aspirin plus clopidogrel) is not needed.

This will reduce the bleeding risk associated with the TAVI/TAVR procedure.

Read the research here!

Posted on 21 February 2018
Author: LCC

Cardiology Information

View all